These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 21821153

  • 1. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [Abstract] [Full Text] [Related]

  • 2. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M.
    Autoimmun Rev; 2011 Sep; 10(11):714-9. PubMed ID: 21570494
    [Abstract] [Full Text] [Related]

  • 3. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
    Giuggioli D, Manfredi A, Colaci M, Manzini CU, Antonelli A, Ferri C.
    Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS, Wong CF.
    J Nephrol; 2007 Sep; 20(3):350-6. PubMed ID: 17557269
    [Abstract] [Full Text] [Related]

  • 6. Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature.
    Giuggioli D, Manfredi A, Lumetti F, Sebastiani M, Ferri C.
    Semin Arthritis Rheum; 2015 Apr; 44(5):518-526. PubMed ID: 25547031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [Abstract] [Full Text] [Related]

  • 11. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S.
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ, Chalk CH, Parks NE.
    Cochrane Database Syst Rev; 2014 Dec 20; 2014(12):CD010404. PubMed ID: 25525951
    [Abstract] [Full Text] [Related]

  • 14. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.
    J Nephrol; 2000 Dec 20; 13(5):352-9. PubMed ID: 11063139
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A, Ferri C, Ferrari SM, Ghiri E, Marchi S, Sebastiani M, Fallahi P.
    J Rheumatol; 2010 Jan 20; 37(1):91-7. PubMed ID: 19918044
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
    De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G.
    Arthritis Rheum; 2012 Mar 20; 64(3):843-53. PubMed ID: 22147661
    [Abstract] [Full Text] [Related]

  • 20. [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
    Ignatova TM, Mukhin NA.
    Ter Arkh; 2012 Mar 20; 84(11):81-8. PubMed ID: 23252255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.